Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Insulin Infusion Sets and Types in T1D Children
NCT06532461Recruiting
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Jul 2024
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of insulin aspart and human insulin in type 1 diabetes mellitus (T1D) (4 arms), sponsored by Steno Diabetes Center Copenhagen. Primary endpoint: Occurrence of hyperechogenicity at infusion sites at 4 months. Started Jul 2024; status: recruiting.
02
Drugs
insulin asparthuman insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT06532461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06532461.